BS ISO 13019:2018 - Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

BS ISO 13019:2018

Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Status : Current   Published : June 2018

Format
PDF

Format
HARDCOPY






Standard NumberBS ISO 13019:2018
TitleTissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis
StatusCurrent
Publication Date11 June 2018
Normative References(Required to achieve compliance to this standard)No other standards are normatively referenced
Informative References(Provided for Information)ASTM F2027-00, ISO 14155-1, ISO 14155-2, ASTM F2212-02, ISO 12891-1, ISO/TS 10993-19, ISO 10993-1, ISO 9000, ISO 14971, ISO 13022, ISO 20391-1, ASTM F2150 - 07, ASTM F2312 - 04, ASTM F2315 - 03, ASTM F2383 - 05, ASTM F2210 - 02, ASTM F2451 - 05
International RelationshipsISO 13019:2018
Draft Superseded By17/30319534 DC
DescriptorsSpecimen preparation, Hygiene, Orthopaedic equipment, Test specimens, Surgery, Surgical equipment, Bioassay, Decontamination, Prosthetic devices, Biological analysis and testing, Records (documents), Sterilization (hygiene), Implants (surgical)
ICS11.040.40
Title in FrenchProduits médicaux issus de l'ingénierie tissulaire. Quantification des glycosaminoglycanes sulfatés (sGAG) pour lévaluation de la chondrogenèse
CommitteeBTI/1
ISBN978 0 580 89425 1
PublisherBSI
FormatA4
DeliveryYes
Pages24
File Size744 KB
Price£182.00


 Your basket
Your basket is empty

Multi-user access to over 3,500 medical device standards, regulations, expert commentaries and other documents


BSOL

The faster, easier way to work with standards


Develop a PAS

Develop a fast-track standardization document in 9-12 months


Worldwide Standards
We can source any standard from anywhere in the world